Researchers can now order their mutation of choice in bit.bio’s opti-ox TM powered human-iPSC derived cells, receiving consistent, defined, cryopreserved products that can be immediately incorporated ...

CAMBRIDGE, England--(BUSINESS WIRE)--bit.bio, the company coding human cells for novel cures, today launches its first set of muscle cell disease model products designed to advance the discovery and ...

MIAMI, March 11, 2026 /PRNewswire/ -- Immorta Bio Inc., a scientific longevity biotechnology company dedicated to Treating Diseases of Aging and Treating Aging as Disease™, today announced ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The microbiome, the vast, tangled ecosystem of bacteria, fungi and other microbes that live in and on us, is increasingly recognised as a major factor in health, nutrition and drug response. A new ...

Biological assailants like fungi, bacteria, and viruses continuously test natural defenses that have evolved over millennia. Newer and stranger particles that originate from burning fuels, harmful ...

Bit Bio Ltd. has announced the addition to its portfolio of ioGlutamatergic Neurons MAPT N279K and ioGlutamatergic Neurons MAPT P301S disease models for frontotemporal dementia (FTD), and early access ...

BioTechniques Digital Editor, Tristan Free, catches up with Guohao Dai, Associate Professor of Bioengineering at Northeastern University (MA, USA), to discuss his recent work making improvements in ...

LONDON & BOSTON [March 2, 2026] — Outpost Bio, a company decoding the hidden interactions that drive human biology, today announced a $3.5 million pre-seed funding round co-led by Merantix Capital and ...

The Luxembourg-founded startup is already in production with multiple top-20 global pharma companies, including a public collaboration with Pfizer. Its $10M seed round is led by redalpine, with the ...